NCM · Financial Statements
bioAffinity Technologies, Inc. (BIAF) Financial Statements
$4.84
NCM: BIAF
Market Cap $2.03M
Overview Financials Dividend bioAffinity Technologies, Inc. most recently reported annual revenue of $6.0M, net profit of $-15.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $3.0M $9.0M $6.0M Operating Profit $-2.0M $-4.0M $-8.0M $-9.0M $-11.0M Net Profit $-6.0M $-8.0M $-8.0M $-9.0M $-15.0M EPS $-1043.55 $-814.50 $-409.50 $-337.50 $-129.90 Op Margin — -83511.5% -314.9% -95.6% -171.6%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $1.0M $12.0M $8.0M $7.0M $11.0M Total Liabilities $17.0M $1.0M $3.0M $4.0M $4.0M Cash $1.0M $11.0M $3.0M $1.0M $6.0M Borrowings $11.0M $0 $2.0M $2.0M $1.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-2.0M $-4.0M $-6.0M $-7.0M $-9.0M Investing Cash Flow $0 $0 $-2.0M $0 $0 Financing Cash Flow $0 $8.0M $0 $1.0M $0 Net Cash Flow $1.0M $10.0M $-9.0M $-2.0M $5.0M Free Cash Flow $-2.0M $-4.0M $-6.0M $-7.0M $-9.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.10 FCF Yield -453.41% Quick Ratio 1.41 Interest Coverage -276.15 Return 1Y -91.78% Return 3Y -98.64% Return 5Y —
Screens featuring this stock